Circulars
Illiquid Securities
https://www.nseindia.com/content/circulars/SURV32757.zip
http://www.bseindia.com/markets/MarketInfo/DispNewNoticesCirculars.aspx?page=20160707-36
Suspension of trading in securities of companies for non-compliances
http://www.bseindia.com/markets/MarketInfo/DispNewNoticesCirculars.aspx?page=20160707-37
![]() |
Securities in Ban For Trade Date 08-JUL-2016:
1 JPASSOCIAT
Results today: South Indian Bank, 8K Miles
![]() |
Market Buzz
Brexit can impact global IT spend, warns Gartner
DoT to issue Rs12,500 crore demand notice to six telcos
Spectrum scam' charge utterly bogus: Prasad
Centre Mulls Raising FDI In Media To 49% vs 26% now
Liberty to bid for Tata Steel units, UK offical to attend board meet today
Tata Motors JLR posts record H1 sales on robust Europe demand
Finance giants, PEs & tech cos eye GE's SBI Card stakes
DLF shortlists 6 buyers for promoters' 40% stake
Aurobindo Pharma: Gets @US_FDA Nod For Generic Methenamine Hippurate
5 PEs in race for 10% stake in Hero FinCorp
US drug regulator clears Lupin's Goa plant
Gujarat Gas Gets Grant Of Authorisation For CDG Network In Anand & Panchmahal
Indo Count will be launching new ranges for all three lifestyle brands this September during New York Home Textile Market Week
Aurobindo Pharma, Emcure , Hetero , Laurus, Lupin and Cadila sign MPP drug license deals
ITD Cementation to bid for Namami Gange project
Broker's Corner
CLSA ON APOLLO HOSPITALS BROKERAGE RADAR: Initiate coverage with Buy rating; Target at ₹1,650
MS On Lupin: Stay Overweight; Target At Rs 1,986/Sh
ICICI Sec On Lupin: Maintain Add Call On The Stock
CS India Strategy: Nifty P/E Is Now Much Above Past Averages
You received this message because you are subscribed to the Google Groups "LONGTERMINVESTORSRESEARCH" group.
To unsubscribe from this group and stop receiving emails from it, send an email to longterminvestorsresearch+unsubscribe@googlegroups.com.
Visit this group at https://groups.google.com/group/longterminvestorsresearch.
For more options, visit https://groups.google.com/d/optout.




No comments:
Post a Comment